Guy van Meter
Corporate Officer/Principal bei Adimab LLC
Ursprung des Netzwerks ersten Grades von Guy van Meter
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH.
11
| Holding Company | Biotechnology | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Guy van Meter
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| INVIVYD, INC. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Founder | |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| ALECTOR, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Avitide, Inc.
 Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Founder Director/Board Member | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Dartmouth College | College/University | Undergraduate Degree Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ankyra Therapeutics, Inc.
 Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA. | Medical/Nursing Services | Founder Director/Board Member | |
| Thayer School of Engineering At Dartmouth | College/University | Director/Board Member Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
National Academies of Sciences
 National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services The National Academies of Sciences provides advisory services in the areas of science, technology, and health policy. | Miscellaneous Commercial Services | Director/Board Member | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| TERNS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| X4 Pharmaceuticals (Austria) GmbH | Director/Board Member | ||
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
| University of Wisconsin | College/University | Undergraduate Degree | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member | |
Amnis Corp.
 Amnis Corp. BiotechnologyHealth Technology Amnis Corp. provides cell imaging and instrument development, manufacturing and marketing services. The Company's ImageStreamX and FlowSight imaging flow cytometers combine the speed and sensitivity of flow cytometry with the power of digital microscopy serving a broad spectrum of Life Sciences research market needs. The company was founded by David A. Basiji, William E. Ortyn and Harold H. Kawaguchi in 1999 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| COMPLETE GENOMICS, INC. | Biotechnology | Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Good Start Genetics, Inc.
 Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member | |
| Mithril II UGP LLC | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 48 |
| Österreich | 2 |
| China | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 6 |
| Finance | 5 |
| Commercial Services | 5 |
| Health Services | 3 |
Operativ
| Director/Board Member | 156 |
| Independent Dir/Board Member | 35 |
| Founder | 20 |
| Chairman | 18 |
| Corporate Officer/Principal | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Terry McGuire | 54 |
| Michael Ross | 44 |
| Ajay Royan | 24 |
| Tillman Gerngross | 11 |
| Philip T. Chase | 8 |
| Laura Walker | 4 |
| Max Vasquez | 3 |
| Eric M. Krauland | 3 |
| Robert Mabry | 1 |
| Peter Tessier | 1 |
- Börse
- Insiders
- Guy van Meter
- Unternehmensverbindungen
